Deipolyi Amy, Bailin Alexander, Hirsch Joshua A, Walker T Gregory, Oklu Rahmi
Division of Vascular & Interventional Radiology, Department of Radiology, New York University Medical Center, New York, New York, USA.
Massachusetts General Hospital, Harvard Medical School, Vascular & Interventional Radiology, Boston, Massachusetts, USA.
J Neurointerv Surg. 2017 Feb;9(2):196-199. doi: 10.1136/neurintsurg-2015-012164. Epub 2016 Feb 15.
To describe findings and outcomes of 331 bilateral inferior petrosal sinus sampling (BIPSS) procedures performed in 327 patients evaluated for Cushing disease (CD).
The radiology department's electronic database was searched to identify all BIPSS procedures (1990-2013). Electronic medical records were used to identify demographics, laboratory, procedural, surgical and pathologic findings.
A total of 331 BIPSS procedures were performed in 327 patients (254 F, 73 M), mean age 41 (range 7-81) years. The overall technical success rate was 88% for bilateral cannulation, though nearly two-thirds of the technical failures had unilateral sampling that diagnosed CD. Of the 331 BIPSS procedures, 40 were performed without, and 291 with stimulation by Acthrel or desmopressin. Sensitivity was 89-94% for unstimulated BIPSS, 96% for stimulated BIPSS, and 77% for MRI. BIPSS lateralization was accurate in about half of patients, compared with 75% accuracy for MRI. Mean inferior petrosal sinus (IPS):peripheral adrenocorticotropic hormone ratio was 17.3 (SE 1.8) at baseline, and 99.2 (SE 14.8) at 3 min, with decreasing values over time. All patients with follow-up after surgical resection for centralizing BIPSS were reported to be cured, with cortisol levels significantly decreased from 19 to 4 μg/dL (p<0.0001). Complications from BIPSS were rare, including groin hematoma (2.5%), but no thromboembolic complications were seen.
BIPSS remains the 'gold standard' for diagnosing CD. Stimulation with Acthrel or desmopressin is key to increasing specificity. When only one IPS can be successfully cannulated, results may still be diagnostic. BIPSS findings cannot be used to accurately lateralize lesions within the pituitary.
描述在327例因库欣病(CD)接受评估的患者中进行的331例双侧岩下窦采血(BIPSS)操作的结果。
检索放射科电子数据库以识别所有BIPSS操作(1990 - 2013年)。使用电子病历确定人口统计学、实验室、操作、手术和病理结果。
327例患者(254例女性,73例男性)共进行了331例BIPSS操作,平均年龄41岁(范围7 - 81岁)。双侧插管的总体技术成功率为88%,不过近三分之二的技术失败病例通过单侧采血诊断出了CD。在331例BIPSS操作中,40例未进行刺激,291例使用促肾上腺皮质激素释放激素(Acthrel)或去氨加压素进行刺激。未刺激的BIPSS敏感性为89 - 94%,刺激后的BIPSS为96%,磁共振成像(MRI)为77%。约一半患者的BIPSS定位准确,而MRI的定位准确率为75%。岩下窦(IPS)与外周促肾上腺皮质激素的平均比值在基线时为17.3(标准误1.8),3分钟时为99.2(标准误14.8),且随时间下降。所有因定位性BIPSS接受手术切除后有随访的患者均报告已治愈,皮质醇水平从19μg/dL显著降至4μg/dL(p<0.0001)。BIPSS的并发症罕见,包括腹股沟血肿(2.5%),但未观察到血栓栓塞并发症。
BIPSS仍然是诊断CD的“金标准”。使用Acthrel或去氨加压素进行刺激是提高特异性的关键。当只能成功插管一侧IPS时,结果仍可能具有诊断价值。BIPSS的结果不能用于准确确定垂体病变的位置。